Poor Glycemic Control Correlates with Iron Deficiency Anemia in Type 2 Diabetes Mellitus

Authors

  • Talitha Imani Kaltsum Faculty of Medicine, Universitas Trisakti, Jakarta
  • Pusparini Pusparini Clinical Pathology Department, Faculty of Medicine, Universitas Trisakti, Jakarta, Indonesia http://orcid.org/0000-0002-3371-5825

DOI:

https://doi.org/10.15850/amj.v10n2.2937

Keywords:

HbA1c, iron deficiency anemia, type 2 diabetes mellitus

Abstract

Background: Glycated hemoglobin (HbA1c) has been used extensively to diagnose and monitor diabetes mellitus (DM). Patients with type 2 DM are at risk of experiencing comorbidities and complications such as iron deficiency anemia (IDA). This study aimed to determine the correlation of HbA1c with iron deficiency anemia (IDA) in type 2 DM.

Methods: This cross-sectional study was conducted on 115 types 2 DM patients at a hospital in South Jakarta, Indonesia from November to December 2021. Data on HbA1c levels and IDA were obtained from medical records.  Data were analysed with the Chi-Square test and significancy at  p<0.05.

Results: In total, 43 men and 72 women with type 2 DM were included, with predominantly age over 45 years (89.6%), had DM for more than ten years (55.7%), had obesity I (53.9%), and with hypertension as the most common comorbidity (65.2%). Furthermore, the patients did not smoke (64.3%), had poor glycemic control ((76.5%) and had anemia (58.3%). There was a significant relationship between HbA1c levels and IDA (p = 0.003).

Conclusions: This study shows a relationship between HbA1c and IDA in type 2 DM, therefore, DM patients with poor glycemic control need to be well monitored for iron deficiency anemia. 

Author Biography

Pusparini Pusparini, Clinical Pathology Department, Faculty of Medicine, Universitas Trisakti, Jakarta, Indonesia

Clinical pathology Department

Downloads

Published

2023-06-30

Issue

Vol. 10 No. 2 (2023)

Section

Articles

License

  1. Authors retain copyright and grant Althea Medical Journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to freely share and remix the work with an acknowledgement of the work's authorship and initial publication in Althea Medical Journal. Althea Medical Journal is licensed under CC BY-NC 4.0
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Althea Medical Journal.